BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 8519079)

  • 1. Lung disease in systemic sclerosis (scleroderma).
    Bolster MB; Silver RM
    Baillieres Clin Rheumatol; 1993 Feb; 7(1):79-97. PubMed ID: 8519079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cardiac and pulmonary involvement in scleroderma].
    Launay D; Hachulla E
    Rev Prat; 2002 Nov; 52(17):1901-7. PubMed ID: 12532867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Systemic sclerosis].
    Legendre P; Mouthon L
    Rev Prat; 2017 Sep; 67(7):775-783. PubMed ID: 30512777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung involvement in systemic sclerosis (scleroderma): relation to classification based on extent of skin involvement or autoantibody status.
    Kane GC; Varga J; Conant EF; Spirn PW; Jimenez S; Fish JE
    Respir Med; 1996 Apr; 90(4):223-30. PubMed ID: 8736656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary hypertension in systemic sclerosis.
    Denton CP; Black CM
    Rheum Dis Clin North Am; 2003 May; 29(2):335-49, vii. PubMed ID: 12841298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pulmonary involvement in systemic scleroderma. Part II. Isolated pulmonary arterial hypertension, bronchopulmonary cancer, alveolar hemorrhage].
    Marie I; Lévesque H; Hatron PY; Dominique S; Courtois H
    Rev Med Interne; 1999 Nov; 20(11):1017-27. PubMed ID: 10586440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and risk factors for left ventricular diastolic dysfunction in a scleroderma cohort.
    Vemulapalli S; Cohen L; Hsu V
    Scand J Rheumatol; 2017 Jul; 46(4):281-287. PubMed ID: 27635465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Systemic sclerosis].
    Schinke S; Riemekasten G
    Internist (Berl); 2019 Dec; 60(12):1251-1269. PubMed ID: 31754753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial to mesenchymal transition (EndoMT) in the pathogenesis of Systemic Sclerosis-associated pulmonary fibrosis and pulmonary arterial hypertension. Myth or reality?
    Jimenez SA; Piera-Velazquez S
    Matrix Biol; 2016 Apr; 51():26-36. PubMed ID: 26807760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary manifestations of scleroderma.
    Arroliga AC; Podell DN; Matthay RA
    J Thorac Imaging; 1992 Mar; 7(2):30-45. PubMed ID: 1578524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung involvement in systemic sclerosis.
    Hassoun PM
    Presse Med; 2011 Jan; 40(1 Pt 2):e3-e17. PubMed ID: 21195581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pulmonary involvement in progressive systemic sclerosis].
    Grisanti M; Vicencio M
    Rev Med Chil; 1986 Oct; 114(10):1002-5. PubMed ID: 3575934
    [No Abstract]   [Full Text] [Related]  

  • 13. [Strategy for early diagnosis of lung involvement in systemic scleroderma].
    Diot E; Valat C; Boissinot E; Giraudeau B; Asquier E; Guilmot JL; Lemarié E; Diot P
    Rev Mal Respir; 2000 Dec; 17(6):1073-80. PubMed ID: 11217502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comprehensive framework for navigating patient care in systemic sclerosis: A global response to the need for improving the practice of diagnostic and preventive strategies in SSc.
    Saketkoo LA; Frech T; Varjú C; Domsic R; Farrell J; Gordon JK; Mihai C; Sandorfi N; Shapiro L; Poole J; Volkmann ER; Lammi M; McAnally K; Alexanderson H; Pettersson H; Hant F; Kuwana M; Shah AA; Smith V; Hsu V; Kowal-Bielecka O; Assassi S; Cutolo M; Kayser C; Shanmugam VK; Vonk MC; Fligelstone K; Baldwin N; Connolly K; Ronnow A; Toth B; Suave M; Farrington S; Bernstein EJ; Crofford LJ; Czirják L; Jensen K; Hinchclif M; Hudson M; Lammi MR; Mansour J; Morgan ND; Mendoza F; Nikpour M; Pauling J; Riemekasten G; Russell AM; Scholand MB; Seigart E; Rodriguez-Reyna TS; Hummers L; Walker U; Steen V
    Best Pract Res Clin Rheumatol; 2021 Sep; 35(3):101707. PubMed ID: 34538573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung involvement in systemic sclerosis.
    Silver RM; Miller KS
    Rheum Dis Clin North Am; 1990 Feb; 16(1):199-216. PubMed ID: 2406808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical aspects of lung involvement: lessons from idiopathic pulmonary fibrosis and the scleroderma lung study.
    Highland KB; Silver RM
    Curr Rheumatol Rep; 2005 Apr; 7(2):135-41. PubMed ID: 15760593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary involvement in systemic sclerosis.
    Shahin AA
    Treat Respir Med; 2006; 5(6):429-36. PubMed ID: 17154672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating endothelin-1 levels in systemic sclerosis subsets--a marker of fibrosis or vascular dysfunction?
    Vancheeswaran R; Magoulas T; Efrat G; Wheeler-Jones C; Olsen I; Penny R; Black CM
    J Rheumatol; 1994 Oct; 21(10):1838-44. PubMed ID: 7837147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation and management approaches for scleroderma lung disease.
    Schoenfeld SR; Castelino FV
    Ther Adv Respir Dis; 2017 Aug; 11(8):327-340. PubMed ID: 28621173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung transplantation in patients with scleroderma.
    De Cruz S; Ross D
    Curr Opin Rheumatol; 2013 Nov; 25(6):714-8. PubMed ID: 24061075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.